Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Potential benefits of neoadjuvant radiotherapy prior to "en bloc" compartmental resection of pure retroperitoneal liposarcomas.
World J Urol
December 2024
Department of Urology and Kidney Transplantation, University Hospital of Rangueil, Toulouse, France.
Retroperitoneal liposarcomas(RPL) are rare malignant tumors, accounting for approximately 15% of soft tissue sarcomas and 0.07-0.2% of all cancers.
View Article and Find Full Text PDFRetroperitoneal leiomyosarcoma diagnosis and management in a chronic kidney disease context: A case report.
Int J Surg Case Rep
November 2024
Department of Surgery A La Rabta Hospital, Tunis, Tunisia; Faculty of medicine of Tunis, Tunis El Manar University, Tunis, Tunisia.
Introduction And Importance: While the treatment approach for sarcomas seems straightforward and well-defined, we often encounter several diagnostic or therapeutic challenges in clinical practice. This article presents a case of retroperitoneal leiomyosarcoma in a patient with chronic kidney disease, highlighting the complexity of managing such cases.
Case Report: A 63-year-old woman with a history of chronic kidney disease presented with a progressively enlarging mass in her right flank.
A rare well-differentiated renal retroperitoneal liposarcoma: a case report.
Ann Med Surg (Lond)
October 2024
Department of Urology, Aleppo University Hospital, Aleppo, Syria.
Article Synopsis
- Retroperitoneal liposarcomas (RPLPSs) are uncommon tumors arising from mesenchymal cells in the peritoneal cavity, with renal cases being especially rare; only 45 instances have been documented.* -
- A case study of a 44-year-old woman revealed that she had RPLPS, identified due to symptoms like hirsutism and an abdominal mass, which was confirmed via imaging and needle biopsy; she successfully underwent surgery.* -
- RPLPSs are primarily asymptomatic until they grow large, categorized into five subtypes, and while they seldom metastasize, they often recur; they can compress nearby structures like the adrenal gland.*
Unexpected Extrarenal Accumulation of Tc-99m Ethylene Dicysteine in a Case of Liposarcoma.
Indian J Nucl Med
August 2024
Department of Nuclear Medicine, School of Medicine, Rajaie Cardiovascular, Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.
Article Synopsis
- Tc-99m EC is a radiopharmaceutical used in renal scintigraphy to evaluate kidney function and detect urinary tract obstructions.
- A case study describes a 70-year-old man with recurrent abdominal liposarcoma exhibiting unusual Tc-99m EC uptake outside the kidneys.
- The lesions identified via abdominal CT scan showed a heterogeneous accumulation of Tc-99m EC, indicating a possible link between the radiopharmaceutical and the presence of liposarcoma.
Giant retroperitoneal liposarcoma with multiple organ involvement: a case report and literature review.
BMC Nephrol
August 2024
Affiliated Yantai Yuhuangding Hospital of Qingdao University, No. 20 East Yuhuangding Road, Yantai, 264000, Shandong, China.
Article Synopsis
- Retroperitoneal liposarcoma (RPLPS) is a rare and challenging cancer, especially when it's larger than 30 cm, which complicates diagnosis and treatment.
- A 58-year-old male was diagnosed with a giant RPLPS measuring 55 cm, which had invaded surrounding organs; he underwent successful surgical resection and was discharged with no recurrence after 6 months.
- Surgery is the most effective treatment for RPLPS, emphasizing the importance of detailed preoperative evaluations, while the necessity of additional therapies like radiotherapy or chemotherapy remains debated.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!